Arthur Cox is very pleased to have partnered with Gibson, Dunn & Crutcher LLP in advising Biosynth Carbosynth, a supplier of critical materials to the life science industry, on its acquisition of Aalto Bio Reagents. The acquisition broadens Biosynth’s capabilities and offering to the in-vitro diagnostic and vaccine development industry in the field of emerging disease.

The Arthur Cox team was led by Michael Coyle (Corporate and M&A) and included Sinéad Crowley and Magda Jasinska (Corporate and M&A), Louise O’Byrne and Grace-Ann Meghen (Employment), Ailish Finnerty and Dearbhla Ní Fhloinn (Tax), Colin Kavanagh and Bridget Clinton (Life Sciences Regulatory), Danielle Conaghan and David Ryan (Environment) and Kenneth Egan and Theresa Kiely (Real Estate).

Read more here.